| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/20/2000 | EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 09/20/2000 | EP0734376B1 Vitamin d amine and amide derivatives |
| 09/20/2000 | CN1056609C Benzoyl guanidines, their production and their use in medicinal compositions |
| 09/19/2000 | US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders |
| 09/19/2000 | US6121300 In a topical cosmetic as skin elasticity improver or wrinkle reducer; compounds such as 3-(2-(3-phenyl-5-isoxazolyl)-2-oxoethyl)-thiazolium; adminsistering to treat cataracts, protein aging and diabetes |
| 09/19/2000 | US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders |
| 09/19/2000 | US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders |
| 09/19/2000 | US6121252 N-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme inhibitors to treat glutamate abnormalities and prostate diseases |
| 09/19/2000 | US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury |
| 09/19/2000 | US6121230 Administering polypeptide acting as vascular endothelial growth factor antagonist to treat and/or prevent endometriosis |
| 09/19/2000 | US6121016 DNA encoding human follicle stimulating hormone receptor, vectors and cells containing such DNA, and methods of use thereof |
| 09/19/2000 | US6120761 Mixture containing histidine stabilizer |
| 09/19/2000 | CA2107484C New arylalkyl(thio)amides, their preparation process and pharmaceutical compositions containing them |
| 09/19/2000 | CA2071538C Hpth (1-37) fragment, its production, drug containing it and its use |
| 09/14/2000 | WO2000053628A2 Genes encoding human potassium channel proteins |
| 09/14/2000 | WO2000053562A1 Retinoid antagonists and use thereof |
| 09/14/2000 | WO2000053184A1 Drug composition for percutaneous absorption |
| 09/14/2000 | WO2000053157A1 Improved powdery pharmaceutical compositions for inhalation |
| 09/14/2000 | WO2000037422A3 Ion channel modulating agents |
| 09/14/2000 | WO2000031263A3 Gtpase associated proteins |
| 09/14/2000 | WO2000004012A8 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF |
| 09/14/2000 | WO1999065228A3 Pharmaceutical combination used to compensate for a testosterone deficiency while protecting the prostate |
| 09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
| 09/13/2000 | EP1034187A1 $i(IN VITRO) AND $i(IN VIVO) GROWTH-PROMOTING PROTEINS AND PEPTIDES FOR KIDNEY EPITHELIAL CELLS |
| 09/13/2000 | EP1033974A1 High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | EP0806948B1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin |
| 09/13/2000 | CN1266368A Heterocyclic vinylethers against neurological disorders |
| 09/13/2000 | CN1266054A Aryl carboxylic acid and tetrazole derivant |
| 09/13/2000 | CN1265917A Medicine for treating lithiasis |
| 09/13/2000 | CN1056374C Tricyclic diazepine vasopression antagonists |
| 09/13/2000 | CN1056305C Medicine for treating prostate hyperplasia and preparation process thereof |
| 09/12/2000 | US6117998 A1 adenosine receptor antagonists |
| 09/12/2000 | US6117912 Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions |
| 09/12/2000 | US6117882 5-HT4 agonists and antagonists |
| 09/12/2000 | CA2051375C Process and compositions for the isolation of human relaxin |
| 09/08/2000 | WO2000052134A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000051986A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/08/2000 | WO2000051979A1 C16 unsaturated fp-selective prostaglandins analogs |
| 09/08/2000 | WO2000051614A1 Inhibitors of prenyl-protein transferases |
| 09/08/2000 | WO2000051613A1 Upper hitch link |
| 09/08/2000 | WO2000051612A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051611A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051547A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051546A2 Bupropion metabolites and methods of their synthesis and use |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 09/08/2000 | WO2000013702A3 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000012497B1 Quinazoline derivatives as medicaments |
| 09/08/2000 | CA2363169A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362778A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362495A1 Inhibitors of prenyl-protein transferases |
| 09/08/2000 | CA2362494A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362493A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362361A1 Bupropion metabolites and methods of their synthesis and use |
| 09/08/2000 | CA2330541A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/06/2000 | EP1033366A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists |
| 09/06/2000 | EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 09/06/2000 | EP1032569A1 Imidazole derivatives, preparation and therapeutic application thereof |
| 09/06/2000 | EP1032562A2 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032412A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells |
| 09/06/2000 | EP1032400A1 Prevention of precipitated acute urinary retention |
| 09/06/2000 | EP1032394A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
| 09/06/2000 | EP1032385A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours |
| 09/06/2000 | CN1265674A 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265654A 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring |
| 09/06/2000 | CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists |
| 09/06/2000 | CN1265643A Anthranilic acid analogs |
| 09/06/2000 | CN1265600A Cloning pigs using donor nuclei from differentiated cells |
| 09/06/2000 | CN1265592A A pharmaceutical composition active in reducing production of MCP-1 protein |
| 09/06/2000 | CN1265591A Coumpound |
| 09/06/2000 | CN1056144C New use of 6-heterocyclic-4-amino-3,4,5-tetrahydrobenz (CD) indoles compound |
| 09/06/2000 | CN1056143C Piperidine derivatives and its use |
| 09/05/2000 | US6114365 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 09/05/2000 | US6114359 Endothelin receptor antagonists |
| 09/05/2000 | US6114338 Heterocyclic compounds |
| 09/05/2000 | US6114334 Piperazine derivatives as therapeutic agents |
| 09/05/2000 | US6113906 Water-soluble non-antigenic polymer linkable to biologically active material |
| 08/31/2000 | WO2000050872A2 A system for cell-based screening |
| 08/31/2000 | WO2000050639A2 Gene sequence variations with utility in determining the treatment of disease |
| 08/31/2000 | WO2000050562A2 Dna encoding snorf25 receptor |
| 08/31/2000 | WO2000050400A1 2-aminopyridines containing fused ring substituents |
| 08/31/2000 | WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 08/31/2000 | CA2362906A1 Dna encoding snorf25 receptor |
| 08/31/2000 | CA2362533A1 Gene sequence variations with utility in determining the treatment of disease |
| 08/30/2000 | EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers |
| 08/30/2000 | EP1030840A1 Cyclic amine derivatives and their use as drugs |
| 08/30/2000 | EP0584290B1 Endothelin antagonists |
| 08/30/2000 | CN2393563Y 裤子 Pants |
| 08/30/2000 | CN1265102A Benzothia (oxa) diazol derivatives and their use as endothelin-receptor antagonists |
| 08/30/2000 | CN1265091A Aminoethylphanoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithasis |
| 08/30/2000 | CN1265037A Soya extract, process for its prepn. and pharmaceutical compsn. |